Editorial (Hot Topic: Treatment of Inflammatory Bowel Diseases: Where Do We Go from here?)

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|9|4|325-325

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.9, Iss.4, 2012-07, pp. : 325-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 4 Inhibitors and the Treatment of Asthma: Where Are We Now and Where Do We Go from Here?

By Giembycz M.A.  

Drugs, Vol. 59, Iss. 2, 2000-02 ,pp. : 193-212

Adis International

Access to resources Recommend Favorite

Acetaminophen safety and hepatotoxicity – where do we go from here?

By Amar Patrick J   Schiff Eugene R  

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 341-355

Informa Healthcare

Access to resources Recommend Favorite

Where Do We Go from Here? The Importance of Initial Values

By Mehta M.A.  

Neuropsychopharmacology, Vol. 27, Iss. 5, 2002-11 ,pp. : 879-880

Elsevier

Access to resources Recommend Favorite

Contingency Management for Smoking Cessation: Where Do We Go from Here?

By  

Current Drug Abuse Reviews, Vol. 1, Iss. 3, 2008-11 ,pp. : 340-349

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 controversy: where are we and where do we go from here?

By Khanna Dinesh  

Inflammopharmacology, Vol. 13, Iss. 4, 2005-09 ,pp. : 395-402

VSP

Access to resources Recommend Favorite